Are you tired of a one-size-fits-all mentality from your CRO or being promised the A-team but getting the B-team instead?
At TMC, we do things differently. We may be small, but we’re never average — delivering a big impact every time.
With TMC, you get a full-service clinical research organisation with access to our team of experts plus a global network of highly skilled and experienced associates.
There’s no ‘B-team’ here.
We partner with you to advance treatments for rare diseases where typical regulatory guidelines or conventional clinical research protocols don’t always apply.
To bring these innovative drugs to the market swiftly and cost-effectively, you need a CRO that’s flexible in its business model, integrated in its approach and tailored in its solutions.
You need a CRO like TMC — the perfect FIT.
Get support throughout the drug development process
As a specialist clinical research organisation, we have extensive experience in clinical research for rare diseases and partner with you throughout the drug development process — from Phase 0 exploratory trials to post-authorisation.
TMC bridges the gap between regulatory submissions, clinical development, pharmacovigilance and combined medical services, guiding you through all phases of clinical trials to design effective clinical studies and secure early-stage approvals — leading to rapid market access.
Post-approval, we can also act as your marketing authorisation holder (MAH), if needed, to maintain safety and efficacy standards and support the commercial success of your product.
Bring your rare disease treatments to patients faster
If you want to maximise your product’s market potential, contact our team today at info@tmcpharma.com or fill in the form to find out more about our CRO services and discuss your project.